Nourish Just Raised $100 Million to Help People Stick With Weight Loss Drugs

Nourish pulled in $100 million in new funding, with Menlo Ventures writing the biggest check. That brings the company’s total value to $1.75 billion. The startup connects people with virtual dietitians through their health insurance, so patients pay little to nothing out of pocket.

Now the company wants to grow its metabolic clinic program. This program pairs weight loss drugs like Ozempic and Wegovy with real coaching on food and daily habits. More and more employers are knocking on Nourish’s door because they need a smarter, cheaper way to deal with obesity in their workforce.

Here is the problem nobody talks about enough. These weight loss drugs cost a fortune. A recent report found that eight out of ten employers are stressed about how fast these costs are climbing. But the drug price is only half the battle. The other half is keeping patients on track long enough to see real results.

Most people quit their medication too soon. And when they do, the weight comes right back. That leads to more doctor visits, more health problems, and even bigger bills for everyone involved. So having a coach in your corner is not just a nice bonus. It is the whole point.

Nourish steps in exactly where other programs fall short. They hand patients a custom meal plan, watch how consistently they take their medicine, and run lab tests to track real progress. This mix of medical support and daily habit coaching is what actually moves the needle.

Meanwhile, insurance companies are changing the rules of the game. They used to care about how many people downloaded an app or logged in each week. Not anymore. Today, they want hard numbers that prove a program cuts their costs. Every digital health company must now show real results or risk losing contracts fast.

Nourish seems to understand this better than most. They give patients easy access to dietitians while also handing insurers the proof they need to justify the spend. That smart combination puts them ahead when signing new insurance deals.

On top of that, the company uses technology to build health plans around each person. They track things like blood sugar and other key markers to catch problems early. This data-driven approach is exactly what big payers want to see before they open their wallets.

Experts agree this space is only going to get bigger. Investors are pouring money into specialized care models that can prove savings over time. The winners will be the companies that connect better health outcomes directly to lower costs, and Nourish is clearly betting it can do both.

The team has already built the tech to handle a much larger patient load. They are also collecting strong data to back up their claims. Both of those moves keep them ahead of competitors who are rushing into the same space.

Simply put, healthcare is changing fast. Real proof now matters more than flashy apps. Patients want better care, employers want lower bills, and insurers want solid numbers. Nourish is trying to deliver all three at once, and a $100 million vote of confidence suggests plenty of people think they can pull it off.